cabozantinib and Skin-Diseases

cabozantinib has been researched along with Skin-Diseases* in 1 studies

Other Studies

1 other study(ies) available for cabozantinib and Skin-Diseases

ArticleYear
Cutaneous leukocytoclastic vasculitis of the leg, ulcerations, and subungual splinter hemorrhages: rare adverse reactions caused by cabozantinib treatment.
    Italian journal of dermatology and venereology, 2022, Volume: 157, Issue:5

    Topics: Anilides; Hemorrhage; Humans; Leg; Nail Diseases; Pyridines; Skin Diseases; Vasculitis, Leukocytoclastic, Cutaneous

2022